First Light Asset Management, LLC Keros Therapeutics, Inc. Transaction History

First Light Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$37.26 - $51.01 $6.6 Million - $9.04 Million	-177,134 Reduced 29.82%	416,830 $16.7 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $64,314 - $92,064	1,552 Added 0.26%	593,964 $25.4 Million
Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $228,849 - $300,317	-5,801 Reduced 0.97%	592,412 $28.4 Million
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $3,336 - $4,814	-120 Reduced 0.02%	598,213 $22.5 Million
Q2 2022 Aug 12, 2022	SELL	$26.03 - $67.04 $1.56 Million - $4.01 Million	-59,812 Reduced 9.09%	598,333 $16.5 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $4.47 Million - $6.29 Million	106,047 Added 19.21%	658,145 $35.8 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $14 Million - $23.8 Million	378,888 Added 218.74%	552,098 $32.3 Million
Q3 2021 Nov 12, 2021	BUY	$29.27 - $43.71 $5.07 Million - $7.57 Million	173,210 New	173,210 $6.85 Million

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.77B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.